Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04877314
Other study ID # Intermittent fasting immune
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 13, 2021
Est. completion date June 15, 2021

Study information

Verified date June 2022
Source Istanbul Training and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Positive effects of calorie restriction on quality of life and diseases are reported. Intermittent fasting, one of the calorie restriction methods, has been shown to be beneficial for health with many metabolic effects, not just calorie restriction. Preclinical studies show the disease-modifying effects of intermittent fasting in animal models on a wide variety of chronic disorders, including obesity, diabetes, cardiovascular disease, cancers, and neurodegenerative brain diseases. There are very few studies evaluating the effects of intermittent fasting on the immune system, and only TNFα, IL6 and IL10 cytokines were evaluated in these studies to evaluate the immune system. In this study, we aimed to evaluate the conditions of inflammatory markers in peripheral blood before and after intermittent fasting period in overweight volunteers with a Body Mass Index between 25 and 30. Volunteers will have intermittent fasting for 3 weeks, which conforms to the 16-hour fasting and 8-hour meal format.


Description:

In a 1997 article by Weindruch and Sohal, they reported that reducing food availability (calorie restriction) throughout life has significant effects on aging and lifespan in animals. There are many modalities for calorie restriction, one of which is intermittent fasting. Intermittent fasting involves having little or no energy intake during a certain period of the day, then free intake of energy for the rest of the day. Some of the modalities applied in this context can be listed as 12 hours fasting-12 hours eating, 16 hours fasting-8 hours eating, 20 hours fasting-4 hours eating. Studies in animals and humans show that most of the health benefits of intermittent fasting are not just the result of decreased free radical production or weight loss. Instead, intermittent fasting elicits cellular responses that can adapt to improve glucose regulation between and within organs, increase stress resistance, and suppress inflammation. During intermittent fasting, cells activate pathways that increase their defenses against oxidative and metabolic stress and remove or repair damaged molecules.Preclinical studies show the disease-modifying effects of intermittent fasting in animal models on a wide variety of chronic disorders, including obesity, diabetes, cardiovascular disease, cancers, and neurodegenerative brain diseases . Periodic opening and closing of metabolism with intermittent fasting not only provides the ketones necessary for cells to use during the fasting period, but also elicits highly regulated systemic and cellular responses to increase mental and physical performance and disease resistance. There are very few studies evaluating the effects of intermittent fasting on the immune system, and only TNFα, IL6 and IL10 cytokines were evaluated in these studies to evaluate the immune system. In one of these studies, it was reported that proinflammatory cytokines of TNFα, IL6, which were measured after intermittent fasting for 30 days for 14 hours, decreased significantly. In this study, the investigators aimed to evaluate the effect of 16-hour fasting and 8-hour intermittent fasting application on overweight volunteers with a Body Mass Index of 25-30 for inflammatory markers in peripheral blood .


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date June 15, 2021
Est. primary completion date May 5, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Bady mass index should be between 25-30 - Male Exclusion Criteria: - Diabetes patients, - Immune deficiency history, - Cancer patients, - Individuals who did not agree to participate in the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Intermittent fasting
30 overweight male volunteers who will have 3 weeks intermittent fasting which has 16 hours fasting and 8 hours eating in a day period.

Locations

Country Name City State
Turkey Istanbul Training and Research Hospital Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Istanbul Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

References & Publications (3)

Di Francesco A, Di Germanio C, Bernier M, de Cabo R. A time to fast. Science. 2018 Nov 16;362(6416):770-775. doi: 10.1126/science.aau2095. Review. — View Citation

Panda S. Circadian physiology of metabolism. Science. 2016 Nov 25;354(6315):1008-1015. Review. — View Citation

Weindruch R, Sohal RS. Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. N Engl J Med. 1997 Oct 2;337(14):986-94. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Cytokine levels IL1, IL6, TNFa, IL10 cytokine levels 3 weeks
Secondary Demographic values Weight as kilograms, Height as meters 3 weeks
See also
  Status Clinical Trial Phase
Completed NCT04647149 - Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity N/A
Completed NCT04953650 - Intermittent Fasting Towards Elevated Blood Pressure N/A
Active, not recruiting NCT05290233 - Time Restricted Eating Plus Exercise for Weight Management N/A
Completed NCT04404413 - High-Intensity Interval Training and Intermittent Fasting on Body Composition and Physical Performance in Active Women N/A
Recruiting NCT05558423 - ZOE Health Study: The Intermittent Fasting Study N/A
Completed NCT02770313 - Weekly ONe-Day WatER-only Fasting InterventionaL Trial for Low-Density Lipoprotein Cholesterol Reduction N/A
Active, not recruiting NCT05344066 - Manchester Intermittent Diet in Gestational Diabetes Acceptability Study N/A
Not yet recruiting NCT06330610 - Evaluation of the Efficiency of Intermittent Enteral Nutrition on Multi-organ Failure From Patients With Mechanical Ventilation in Intensive Care Unit N/A
Not yet recruiting NCT06299020 - Risks of Intermittent Fasting in Patients With Primary Adrenal Insufficiency N/A
Recruiting NCT03789409 - Intermittent Fasting Following Acute Ischemic Stroke N/A
Not yet recruiting NCT06302231 - Effects of Time-restricted Eating and Aerobic Exercise Training in Women With Overweight and Obesity N/A
Recruiting NCT05760339 - Intermittent Fasting Versus Carbohydrate Drinks Before Surgery N/A
Recruiting NCT06429124 - Time Restricted Eating in Alzheimer's Disease (TREAD) Early Phase 1
Enrolling by invitation NCT06105372 - Ramadan Fasting, Microbiota and FABP4
Completed NCT04732130 - Monitoring During Different Intermittent Fasting Protocols in Non-Obese Adults N/A
Completed NCT05422391 - The Acute Effects of Caloric Restriction on Anthropometrics, Metabolism, and Cardiovascular Health in Overweight Adults N/A
Recruiting NCT05136313 - Healthy vs Unhealthy Obesity: Mehanistic Insights and Effects of Time-Restricted Eating N/A
Not yet recruiting NCT06323889 - Longitudinal Monitoring During Intermittent Fasting Protocols in Obese Adults N/A
Completed NCT01378208 - How Often Should We Eat N/A
Recruiting NCT04873648 - Effect of Fasting and Calorie-Restricted Diets on Dopamine and Serotonin Levels Among Obese Women With BED and FA N/A